Semaglutide and UK law
Semaglutide is a UK licensed prescription-only medicine, branded as Wegovy and Ozempic. This page summarises how UK regulation treats lawful supply, NHS access, private routes, and the considerable problem of counterfeit and 'research only' product.
What semaglutide is and how it is licensed
Semaglutide is a GLP-1 receptor agonist. In the UK, semaglutide-containing medicines are licensed for distinct indications: Ozempic for type 2 diabetes, and Wegovy for chronic weight management within defined eligibility criteria. Both are prescription-only (UK POM). The specific licensed indications are set out in each product's marketing authorisation and Summary of Product Characteristics.
NHS access
NHS access to semaglutide-based medicines depends on the indication and the relevant NICE technology appraisal. For type 2 diabetes, semaglutide can be prescribed within NHS pathways. For weight management, eligibility is more restrictive and depends on NICE guidance and local commissioning of specialist weight-management services. Check current NICE position before drawing conclusions.
Private access
Private prescribing of semaglutide is lawful in the UK when carried out by a registered prescriber after appropriate clinical assessment, with dispensing by a regulated UK pharmacy. The quality of online private services varies. Light-touch questionnaires that produce a prescription in seconds are not the same as an appropriate clinical consultation.
What “research only” semaglutide is
Some grey-market sellers list semaglutide powder for “research use only”. The product offered is rarely verifiable as genuine UK pharmaceutical-grade semaglutide. The framing does not insulate sellers from UK rules if the product is presented or used as a medicine. From a consumer-safety angle, the identity, purity, dose accuracy, sterility, and provenance are all unverified.
Counterfeit pen risk
Counterfeit semaglutide and tirzepatide pens are a significant UK safety issue. The MHRA has issued public warnings. The lawful route — registered prescriber, regulated pharmacy, genuine packaging — is also the safest one. See our safety guide.
Red-flag claims
If you see wording like this on a seller, clinic, or social-media advert, treat it as a warning sign rather than a benefit.
“Ozempic without prescription, fast UK delivery”
Cannot be both legal and quick. UK POMs require a valid prescription and a regulated pharmacy.
“Compounded semaglutide — same as Ozempic”
UK compounding rules are narrow. Most 'compounded semaglutide' offers are unregulated grey-market product, not genuine compounded medicine.
“Research-grade semaglutide for personal study”
Labelling that hints at human use combined with 'research only' wording is exactly the contradiction MHRA looks at.
“Pens at half the clinic price”
Authentic UK supply has not become dramatically cheaper. Significant discounts point toward counterfeit or repackaged product.
“Buy online with no questions asked”
Asking questions is a feature, not a bug, of regulated supply. Its absence is a regulatory red flag.
Sources & further reading
- MHRA — gov.uk
- NICE TA875 — semaglutide for managing overweight and obesity — nice.org.uk
- NHS — obesity treatment (references Wegovy) — nhs.uk
- MHRA Drug Safety Update (publication landing) — gov.uk
Filter by therapeutic area for GLP-1 / counterfeit pen alerts.
- Yellow Card — report suspected side effects — yellowcard.mhra.gov.uk
- WADA Prohibited List — wada-ama.org
Frequently asked questions
- Is semaglutide legal in the UK?
- Yes, semaglutide is a UK licensed medicine (Wegovy for weight management; Ozempic for type 2 diabetes). It is prescription-only. Lawful supply requires a valid UK prescription and a regulated dispensing pharmacy.
- Can I buy semaglutide online without a prescription?
- Not lawfully through a UK route. A seller offering semaglutide without a prescription is outside the UK regulatory framework and the product may be counterfeit, mis-dosed, or contain a different active ingredient.
- Is semaglutide available on the NHS?
- Access depends on NICE guidance and local commissioning. Eligibility criteria and the specific service involved (e.g. tier 3 weight management) vary. Check current NICE technology appraisal status and speak to your GP.
- What about private clinics and pharmacies?
- Private prescribing in the UK is lawful when carried out by a registered prescriber and dispensed by a regulated pharmacy. Quality of consultation varies; some online services have been criticised for thin clinical assessment.
- Is 'research only' semaglutide legal?
- It is rarely a sensible legal or safety route. The product is unlikely to be genuine UK pharmaceutical-grade semaglutide, and 'research only' labelling does not displace UK rules where the product is marketed or used as a medicine.
- Is semaglutide on the WADA Prohibited List?
- Athletes should verify current WADA / UKAD status directly. The status of GLP-1 receptor agonists can change. The strict-liability principle applies regardless.